This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

For The First Time Ever, "Anti-Aging" Pill Coming To Neiman Marcus

NEW YORK, April 18, 2013 /PRNewswire/ -- Recently, it seems human growth hormone has been gaining an almost "religious" following. It's been featured on The Today Show, Good Morning America, Fox News, CNN, The Dr. Oz Show, and in Shape magazine and Vanity Fair. And now, starting on May 1, luxury department store chain Neiman Marcus will be adding to the frenzy by allowing the growth hormone booster SeroVital™-hgh into its stores.

So why all the fuss about human growth hormone (hGH)? Simple. hGH disciples… and to many, hGH therapy is truly a religious experience… believe growth hormone can help reduce body fat, increase lean muscle mass, boost mood, heighten sex drive, give them plenty of energy, get rid of wrinkles and tighten saggy skin… making them look and feel decades - not years, but decades - younger.

The problem has been that until recently, the best way to increase our hGH levels was through the use of expensive prescription injections (costs can run as high as $1500 per month). In addition to their high cost, synthetic hGH injections are also extremely controversial, because some experts fear that introducing synthetic hGH into the body may upset the natural production of hGH.

The controversy over synthetic injections seems to be a big part of the reason everyone from celebrities, CEOs and Wall Street execs to housewives, models and politicians seems to be interested in finding a "natural" way to increase hGH levels. So it's no surprise that when an oral compound capable of increasing mean, endogenous, bioactive, serum (blood) growth hormone levels by 682% was presented at the prestigious Obesity Society's most recent Scientific Meeting in San Antonio, Texas, and then again at the Academy of Women's Health's 21 st Annual Congress in Washington, D.C., it created a serious stir.

SanMedica International™ received the rights to sell the formula that was the subject of these research findings under the trade name SeroVital, and although it's only been available commercially for a short time, it's already been featured in Shape, on Radar Online, and on New York Live, and makeup artists have been gushing about it in magazines like Star and OK! Part of the reason for all the buzz surrounding the SeroVital formula is that rather than introducing synthetic hGH into the body like the injections do, this oral supplement raises the body's own, natural levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. SeroVital has not only made it more affordable for people to raise their hGH levels, but has given them a clinically proven way to raise them naturally.

"We're very excited about and grateful for all the amazing press we've been getting about SeroVital," says Chantelle Daines, spokesperson for SanMedica, "but we believe that it's the groundbreaking research behind SeroVital that is really capturing people's attention and convincing them to try it. And the double-blind, placebo-controlled clinical trial proving SeroVital caused a mean 682% increase in growth hormone levels is definitely opening doors for SeroVital. It's a big part of the reason Neiman Marcus agreed to carry SeroVital in its stores!"

Of course - despite all the research - some skeptics are saying SeroVital sounds too good to be true. So is there a catch? Well, there are three. First, as with HGH injections, SeroVital is not a "magic bullet," but one part of a healthy lifestyle choice including a sensible diet and exercise regimen.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs